Carl Schoellhammer

Carl Schoellhammer is an Associate Partner at DeciBio, specializing in management consulting within growth strategy, mergers and acquisitions, and biopharma pipeline prioritization across the healthcare and life science sectors. Additionally, Carl serves as Managing Director at DeciBio BroadOak BioTools Venture Fund, focusing on investments in life science technologies to advance precision medicine. As the founding CEO and Director of Suono Bio, Carl has led the development of innovative therapeutic products utilizing ultra-rapid delivery technology for inflammatory-mediated diseases. Academic qualifications include a Ph.D. in Chemical Engineering from the Massachusetts Institute of Technology, where Carl also completed postdoctoral research. Prior experience includes roles at Merck, Flagship Ventures, and leadership in the MIT $100K Entrepreneurship Competition.